Skip to main content
NewslettersWatchlist

Oncolytics Bio(ONC-T)
TSX

Today's Change
Real-Time Last Update

Oncolytics Bio

322 11th Avenue S.W
Suite 804
Calgary AB T2R 0C5 CAN
P: 403-670-7377
F: 403-283-0858
https://www.oncolyticsbiotech.com

Sectors & Indices

Sector
Industry
Employees

Profile

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

Key Executives

NameTitle
Matthew C. CoffeyCEO/Co-Founder/Director/President
Kirk J. LookCFO
Allison HagermanVice President, Divisional
Thomas C. HeinemanChief Medical Officer
Amy G. LevinVice President, Divisional

More from The Globe

Advantage Energy director buys as stock rallies
Ted Dixon
The close: S&P 500 higher but TSX slips as traders await key U.S. inflation data
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8, 2024. REUTERS/Brendan McDermid/File Photo
opinion
You’ve heard of dollar-cost averaging. How about trying dollar-cost selling?
Nancy Woods
The close: Dow up seven in a row as jobs data boosts rate-cut hopes; TSX at new record high
NEW YORK, NEW YORK - MAY 03: Traders work on the floor of the New York Stock Exchange (NYSE) on May 03, 2024 in New York City. The Dow surged over 400 points in morning trading as new economic numbers showed that the central bank may cut interest rates sooner than expected. (Photo by Spencer Platt/Getty Images)
25 stocks most added to Watchlists
The close: TSX gives up winning streak as Shopify posts record decline
A trader works on the trading floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 5.
The close: S&P 500 and TSX extend winning streaks, despite Disney drag
A specialist trader works at his post on the floor at the New York Stock Exchange (NYSE) on April 29.
How pro money managers are balancing exposure to Canadian and U.S. stocks
Rob Carrick

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.